API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
0
Other Suppliers
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.fiercepharma.com/manufacturing/nabriva-hits-another-fda-setback-complete-response-letter-for-antibiotic-contepo
https://www.biospace.com/article/releases/nabriva-therapeutics-receives-complete-response-letter-from-fda-on-nda-for-contepo-fosfomycin-for-injection/
https://www.ema.europa.eu/en/news/recommendations-restrict-use-fosfomycin-antibiotics
https://www.globenewswire.com/news-release/2020/01/08/1968089/0/en/Nabriva-Therapeutics-Receives-FDA-Acknowledgement-of-New-Drug-Application-Resubmission-for-Intravenous-CONTEPO-fosfomycin-for-Injection.html
https://www.globenewswire.com/news-release/2020/01/08/1968089/0/en/Nabriva-Therapeutics-Receives-FDA-Acknowledgement-of-New-Drug-Application-Resubmission-for-Intravenous-CONTEPO-fosfomycin-for-Injection.html
https://www.globenewswire.com/news-release/2020/01/08/1968089/0/en/Nabriva-Therapeutics-Receives-FDA-Acknowledgement-of-New-Drug-Application-Resubmission-for-Intravenous-CONTEPO-fosfomycin-for-Injection.html
http://www.globenewswire.com/news-release/2019/12/20/1963355/0/en/Nabriva-Therapeutics-Resubmits-New-Drug-Application-for-Intravenous-CONTEPO-fosfomycin-for-Injection.html
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-10-13-december-2018
https://www.pharmaceutical-technology.com/comment/nabriva-therapeutic-antibiotics/
https://www.fiercebiotech.com/biotech/bristol-myers-tsinghua-university-pen-drug-discovery-pact
http://www.prnewswire.com/news-releases/zavante-therapeutics-closes-45-million-series-a-financing-in-support-of-us-development-for-a-first-in-class-injectable-antibiotic-300243155.html